How Effective is Botulax for Crow’s Feet | Treatment Details, Results, and Duration

Botulax is highly effective for crow’s feet, usually taking effect in 3 days, reaching a visual peak at 14 days, and the effect is maintained for 4 to 6 months. Its high-purity botulinum toxin formula precisely relaxes the muscles around the eyes and smooths dynamic wrinkles. It is recommended that you choose a regular medical institution and have it administered precisely by a professional doctor to ensure that the wrinkle removal effect is natural, safe, and long-lasting.

Treatment Details

For Botulax injections targeting crow’s feet, 3 to 4 points are usually set on each side of the eye area. A 100U dose is diluted with 0.5% concentration of saline, with 0.1ml (approx. 4 Units) injected per point. During injection, the is at a 15-degree angle to the skin, the depth is controlled at 2 to 3 mm subcutaneously, avoiding the orbital rim by 10 mm. The entire process takes about 10 minutes, requires no general anesthesia, and normal social activities can be resumed immediately after the procedure.

Muscle Activity Assessment

Before performing Botulax injections, the doctor’s assessment of the activity of the Orbicularis Oculi muscle is the basis for determining the dose distribution. This muscle belongs to the sphincter group, distributed around the eye socket, and the repeated contraction of its lateral fibers is the direct cause of crow’s feet. The evaluation is usually carried out from two dimensions: static and dynamic. The doctor will ask you to maintain a facial expressionless state to observe whether there are static creases at the outer canthus. According to the Glogau grading standard, if deep folds already appear on the skin in a static state, it usually means that the collagen in the dermis has been damaged. At this time, relying solely on botulinum toxin may not be able to completely eliminate the lines, and subsequent skin repair needs to be combined. Then comes the dynamic assessment phase, where you need to make maximum smiling or squinting movements. The doctor will judge the strength of the muscles by observing the displacement distance of skin stress points. Studies have shown that during strong contraction, the contractile force of the lateral Orbicularis Oculi fibers can cause a skin displacement of 2 to 5 mm. Crow’s feet are usually divided into three types: upper type (lines extending toward the upper forehead), middle type (extending horizontally toward the temples), and lower type (extending toward the lower cheekbones). This classification directly affects the distribution of points. For example, when there are more lower-type lines, the injection points need to be shifted slightly downward, but must strictly avoid the starting points of the zygomaticus major and zygomaticus minor muscles to prevent facial stiffness caused by asymmetric smiles or drooping corners of the mouth.

During the assessment process, anatomical safety boundaries are a guideline that must be 100% followed. The doctor will use fingers to touch and locate your Orbital Rim. All injection points must be located at least 1 cm outside this edge. This distance is to ensure that within the 5 to 10 mm radius of Botulax diffusion under the skin, the liquid will not penetrate into the eye socket and act on the levator palpebrae superioris or extraocular muscles. If unintended diffusion of the liquid occurs, it may lead to ptosis or diplopia lasting for 2 to 4 weeks. For subjects with extremely thin skin (such as Types I and II in the Fitzpatrick skin classification), vascular visibility is high, and the doctor will avoid visible lateral incisor veins and superficial temporal vein branches to reduce the probability of bruising after the procedure. Clinical data shows that male facial muscle fibers are usually 20% to 30% thicker than those of females, and skin thickness is higher, which means that males usually require a higher initial dose. Under the same severity of crow’s feet, 10 Units per side for females often achieves ideal results, while males may need 15 to 20 Units to completely inhibit the strong contraction of the Orbicularis Oculi. The doctor will also check for asymmetry on the left and right sides of the face. Approximately 60% of subjects have unequal muscle strength around the eyes on the left and right sides, which is often related to long-term side-sleeping habits or unilateral chewing habits. Through quantitative assessment, the doctor may inject 12 Units on one side and only 8 Units on the other to achieve a visual balance after the procedure. Regarding the specific selection of injection points, a fan-shaped distribution method is usually adopted. The first point is set on the horizontal line of the corner of the eye, 1.5 cm from the outer canthus; the second and third points are located 1 cm above and below the first point respectively. If your crow’s feet are distributed over a long range, the doctor may add a fourth point located above the zygomatic arch. The injection volume for each point must be accurate to 0.1 ml. Using 30G or 32G ultra-fine , insert at a shallow angle of 10 to 15 degrees into the subcutaneous layer. After the assessment is completed, the doctor will record your muscle activity data in detail, including the length of wrinkles (usually in millimeters) and the grading score. These data not only determine the dosage of Botulax for this session but will also serve as a comparison baseline for follow-up visits 4 to 6 months later. For first-time users, doctors often follow the principle of “less rather than more,” giving a conservative dose at the first visit and scheduling a follow-up 14 days later. Because the full effect of botulinum toxin in the eye area tissues usually manifests in 7 to 14 days, at which time if there is still minor local activity, 2 to 4 Units can be supplemented.

Injection Operation Steps

Usually, 2.5 ml of preservative-free 0.9% sodium chloride saline is injected into a 100 Units bottle of Botulax. During reconstitution, the saline should flow slowly down the bottle wall to avoid generating a large number of bubbles or violent shaking, preventing damage to the protein molecular structure which would lead to a decrease in efficacy. The concentration of the solution after reconstitution is 4 units per 0.1 ml. The doctor will choose an ultra-fine disposable with a capacity of 0.3 ml or 0.5 ml, equipped with a 30G or 32G 4 mm short. The ultra-fine can significantly reduce tissue trauma during the puncture process and reduce the probability of bruising caused by capillary rupture. After drawing the liquid, air in the lumen must be expelled to ensure the injection volume reading is accurate to 0.01 ml.

The positioning process before injection requires the doctor to touch and confirm the location of the Lateral Orbital Rim. All injection points must be strictly set within the safety zone at least 1 cm outside the orbital rim. The first is usually positioned on the horizontal axis outside the corner of the eye, about 1.5 cm from the outer canthus. The second and third are located above and below the first respectively, with the three points arranged in a fan or arc shape. If the subject’s crow’s feet extend above the cheekbone, a fourth point needs to be added below. The injection dose for each point is usually set to 3 to 4 Units. During insertion, the doctor will use the other hand to gently pull the skin around the eyes tight to make the target muscle layer flatter. The is inserted into the subcutaneous layer at a very small angle, and the injection process must be slow and steady, with a single injection time controlled between 2 to 3 seconds. In clinical operations, precise mastery of anatomical layers determines the final visual effect. The Orbicularis Oculi is distributed shallowly outside the corner of the eye, so deep muscle injection is not required. When injecting the liquid, due to increased local pressure, a micro-“wheal” with a diameter of about 3 to 5 mm usually bulges on the skin surface. This is a normal phenomenon, indicating that the liquid has been accurately delivered to the target area. If there is no resistance during injection, it may mean the has gone too deep into the fat pad, which will lead to the efficacy being diluted or the action time shortened. For subjects with extremely thin skin, the injection depth will be further reduced to 1.5 mm. The doctor will deliberately avoid visible blue venous plexuses, especially the lateral incisor vein branches located on the temple side. In case the touches a blood vessel, the must be withdrawn immediately and continuous pressure applied with a sterile cotton swab for 60 to 90 seconds to prevent the formation of subcutaneous hematoma. After completing a total of 6 to 10 injection points on both sides, the doctor will check if there is any fluid leakage or tiny bleeding points at the injection sites. It is strictly forbidden to perform any form of local massage or rubbing after the injection is finished. Botulinum toxin molecules need 4 to 6 hours to complete binding with receptors on nerve endings. External pressure will cause the liquid to diffuse toward the nose or upper eyelid, thereby triggering temporary diplopia or ptosis. Post-procedure, the subject should maintain a vertical facial position and avoid immediately lowering the head or lying in bed. For subjects with high pain sensitivity, local ice packs can be applied for 10 minutes before injection. Low temperature not only numbs the nerve endings but also causes subcutaneous small blood vessels to contract, further improving the safety of the operation. All medical waste, including and with residual liquid, must be strictly disposed of in sharps boxes according to biohazard standards. Botulax is extremely sensitive to heat after reconstitution and should be temporarily stored in a refrigerated environment of 2°C to 8°C and injected within 4 hours. Clinical data shows that as the reconstitution time extends, the diffusion radius of the drug will undergo uncontrollable changes. Before each injection, the doctor will re-check the scale on the to ensure that the total dose on one side does not exceed the predetermined range of 12 to 15 Units.

Post-procedural Behavioral Restrictions

Within the first 4 hours after completing Botulax injections for crow’s feet, maintaining a vertical body posture is the primary operational norm for preventing unintended diffusion of the liquid. From a physiological perspective, in the initial stage after botulinum toxin molecules enter the Orbicularis Oculi, it takes a certain amount of time to complete binding with SV2 receptors on nerve endings. During this process, the liquid still has a certain fluidity in the tissue gaps. If lying flat, side-sleeping, or significantly lowering the head is performed at this time, gravity will cause the liquid that has not yet fully bound to penetrate along the fascia layer to the periphery. Especially for the eye area, where the anatomical structure is extremely delicate, once the liquid drifts inward and upward into the eye socket, it may touch the levator palpebrae superioris, leading to ptosis lasting 2 to 4 weeks, or affecting the muscles that control eyeball rotation, producing temporary diplopia. Therefore, within 4 hours after the procedure, strictly avoid activities such as napping or lowering the head to tie shoelaces.

The head must be kept vertical to the ground within 4 hours after the procedure. Lying flat, side-sleeping, or leaning forward is prohibited to ensure that the initial distribution state of Botulax liquid in the Orbicularis Oculi is not changed by gravity.

Control of the temperature environment is usually concentrated in the 24 to 48 hours after the procedure. High-temperature environments significantly induce local capillary dilation and speed up blood circulation. When blood flow at the injection site increases, the botulinum toxin molecules that were supposed to act on the local nerve endings will be carried away from the target muscle too quickly by the blood circulation. This not only weakens the relaxation effect on crow’s feet but may also lead to the drug entering the systemic circulation. Clinical observations show that entering a sauna, steam room, or taking a long hot shower above 38°C (100°F) within 24 hours after the procedure increases the probability of redness and swelling at the injection site by about 15%. In addition, thermal effects may aggravate the inflammatory response at the eye, prolonging the time for micro-wheals to disappear. It is recommended to wash the face with water near room temperature within two days after the procedure and avoid any form of facial hot compress operations.

Saunas, hot yoga, or hot showers exceeding 38°C are strictly prohibited within 48 hours after the procedure to avoid accelerated drug metabolism or unnecessary local tissue swelling caused by vascular dilation.

In clinical operations, every injection point set by the doctor has an expected diffusion radius of 5 to 10 mm to ensure coverage of the entire crow’s feet distribution area. If you rub the corners of your eyes immediately after the procedure, or perform professional facial massages or use high-frequency vibrating facial cleansers within 7 days, external force will force the liquid across anatomical boundaries. If the liquid is squeezed and diffused downward, it may accidentally injure the zygomaticus major or zygomaticus minor muscles. These muscles are responsible for lifting the corners of the mouth; once inhibited, it will cause the smile to become stiff or asymmetric. In addition, using makeup remover cotton to vigorously rub the eye area skin too early will also destroy the initial healing of the eye and increase the risk of pigmentation.

Massage, rubbing, or using beauty devices on the eye area is prohibited within 7 days after injection to prevent external force from forcing the liquid to diffuse to non-target muscle groups, resulting in restricted expressions.

It is recommended to stop high-intensity aerobic exercise (such as HIIT, long-distance running, or strenuous cycling) within 3 to 5 days after the procedure. Strenuous exercise will cause an instantaneous rise in blood pressure and heart rate. For the microvessels around the eyes that have just undergone puncture, this pressure fluctuation easily induces delayed bleeding, forming visible purple bruises. At the same time, heavy sweating may lead to sweat flowing along the skin surface to the eye. If the wound is not completely closed, there is an extremely low probability of infection risk. Statistics show that subjects who perform weight training within 24 hours after the procedure are 25% more likely to have subcutaneous ecchymosis at the injection site than subjects who rest quietly.

It is recommended to gradually resume light exercise after 72 hours post-procedure. High-intensity weightlifting or handstand movements that cause facial congestion should be avoided within 5 days to maintain the stability of the capillary pressure around the eyes.

Alcoholic beverages should be avoided within 24 hours after the procedure because ethanol has the effect of dilating blood vessels, which will aggravate the congestion of subcutaneous tissues. More importantly, within 5 to 7 days after the procedure, medications with anticoagulant effects such as aspirin, ibuprofen, high-dose vitamin E, or ginkgo biloba extract should be avoided as much as possible. These substances inhibit the aggregation of platelets, making it difficult for the tiny wounds generated during injection to be quickly sealed. Although Botulax itself does not affect blood coagulation, the intervention of the aforementioned drugs will turn originally fine marks into purple bruises that take a week to fade. In terms of skincare, it is not recommended to apply products containing high concentrations of fruit acid, retinol (Vitamin A), or Vitamin C on injection points within 24 hours after the procedure to avoid contact dermatitis.

Anticoagulant drugs such as aspirin and alcohol intake should be suspended within one week after the procedure, and irritating skincare ingredients should be avoided to reduce the risk of subcutaneous bleeding and protect the integrity of the skin barrier.

Results

Clinical data shows that the improvement rate of Botulax on eye area lines exceeds 91%. After injecting a total of 12-24 units at the corners of both eyes, the effect usually manifests within 24-72 hours. Ideal status can be reached after 14 days, at which time the average depth of wrinkles caused by expression activities is reduced by more than 75%. Its 900kDa molecular structure ensures the action range of the drug within the target muscle. The effect generally lasts for 12-16 weeks, and the recommended re-treatment interval is 4 months.

Onset time

Botulax (100 Units specification, commonly diluted with 2.5ml saline clinically) diffuses and penetrates within a radius of 5mm to 10mm around the injection point in the first 24 hours after entering the eye area tissue. The 900kDa molecular complex structure of Botulax ensures the stability of the liquid in the target Orbicularis Oculi, reducing the risk of diffusion to surrounding non-target muscles. At the molecular level, the heavy chain of botulinum toxin attaches to receptors on nerve endings, then the light chain enters the cell and begins to cut the SNAP-25 protein. This protein is an essential medium for the release of the neurotransmitter acetylcholine into the synaptic cleft. In the first 12 hours after injection, although the biochemical reaction has started, the muscle contraction ability remains at the baseline level because the pre-stored acetylcholine in the nerve endings is still functioning.

Entering the window of day 3 to day 5, the inhibitory effect of Botulax on muscle tension begins to show visual differences. At this time, patients will feel that the muscle response at the outer corner of the eye becomes slightly sluggish during facial expression activities, which is a signal that the nerve signal has been successfully intercepted. For mild crow’s feet (i.e., dynamic lines appearing only when smiling), the improvement at this stage is most obvious, and fine creases on the skin surface begin to change from deep to shallow. According to clinical observation data for 120 subjects, about 65% of people reported wrinkles smoothing significantly around the 4th day. At this time, because muscle activity is reduced, blood circulation in subcutaneous tissue remains steady. Without the physical loss caused by repeated squeezing, the visual texture of the skin barrier will also appear fuller due to the uniform distribution of moisture. Between day 7 and day 10, the relaxation effect of Botulax on the Orbicularis Oculi enters a high-speed progression period. The skin around the corners of the eyes will present a natural sense of smoothness. Shallow surface lines that may have existed in a static state (i.e., dermis creases formed by long-term squeezing) will also stretch out due to the complete “quiescence” of the underlying muscles. Experimental data shows that muscle contractile force at this time is only about 20% of that before injection. For the group over 40 years old with moderate to severe crow’s feet, this period is the most steep slope for wrinkle improvement. The area covered by injection points (usually 3-4 points per side, 3-4 Units per point) has achieved complete drug effect fusion. The fan-shaped area outside the eye is visually widened, giving an impression of a more open eye area and disappearance of fatigue.

Upon reaching the final observation point on day 14, Botulax has completely blocked nerve communication for selected muscle fibers. This is the benchmark time point for evaluating treatment effects and the statutory date for clinical doctors to decide whether micro-“touch-ups” are needed. At this moment, the smoothness of the skin around the eyes reaches its peak. Even with large expressions like laughing, radial wrinkles will not extend above the cheekbones. For those with normal metabolic rates and medium muscle thickness, the skin at the injection site will show a faint luster, attributed to the epidermis no longer being subject to disorderly pulling from the muscles below. This state usually stabilizes for 12 weeks to 16 weeks. Muscle metabolic levels, individual exercise frequency, and local body temperature will all fine-tune this timeline. For example, people with extremely fast metabolism may reach the peak early on day 10.

Visual Improvement Grading

When evaluating the therapeutic effect of Botulax on crow’s feet, clinicians usually use the Facial Wrinkle Scale (FWS) for quantitative grading, which divides eye corner lines into four grades: 0 (none), 1 (mild), 2 (moderate), and 3 (severe). For subjects aged 18 to 65, choosing 3 standard injection points on the lateral side of each Orbicularis Oculi with a total dose controlled at 12 to 24 Units, the trajectory of visual improvement presents a high degree of logic. For early users with an FWS grade of 0 or 1, the effect of Botulax is more reflected in the fine-tuning of skin smoothness. 3D skin imaging 14 days after injection shows an average decrease in epidermal roughness of 22%.

• Grade 0 (No wrinkles): The injection area is completely smooth. Even when squinting or laughing at maximum effort, there are no visible radial creases outside the corner of the eye, and the skin remains tight.
• Grade 1 (Mild): The eye area is smooth at rest. 2-3 superficial lines appear only when making expressions. The length of the lines usually does not exceed 8mm, and the depth is extremely shallow.
• Grade 2 (Moderate): There may be 1-2 fine marks at rest. Obvious radial folds appear during dynamic movements. The lines may extend to the upper edge of the cheekbone but have not formed deep depressions.
• Grade 3 (Severe): Deep and long creases are visible even at rest. The skin shows obvious physical overlap. Wrinkles are deeply set and dense during dynamic movements, and even accompanied by sagging skin.

For patients at the Grade 2 (Moderate) level, after the 900kDa molecular complex of Botulax penetrates into the Orbicularis Oculi, it will quickly lock onto the active muscle fibers that cause skin compression. In this grade, the visual improvement is most significant because Grade 2 wrinkles are primarily driven by dynamic contraction. Clinical comparison data shows that after receiving injections of 10-12 Units per side, more than 88% of moderate wrinkle patients can drop to Grade 0 or Grade 1 within two weeks. This leap in grading means that when observed at a social distance (approx. 50cm), the visual shadows originally generated by excessive muscle contraction completely disappear. Due to the high purity of Botulax (over 99.5%), its interception of nerve signals is very precise, allowing the eye area to regain smoothness without “strange expressions” caused by compensatory contractions of surrounding tissues. This natural look is an important indicator of the visual score transformation from Grade 2 to Grade 1.

Visual improvement for Grade 3 (Severe) involve more complex anatomical changes. Severe crow’s feet are usually accompanied by a break in collagen in the dermis, forming permanent static marks. In this case, the main task of Botulax is to release the continuous pulling of the underlying muscles on the skin, providing an environment for the skin’s own repair. Observation found that after severe patients injected about 20 Units of Botulax, although they could not achieve a completely “zero wrinkle” vision like mild patients, the visual length of their wrinkles would be shortened from an average of 15mm to about 6mm. Crease shadows originally as deep as 0.5mm will become shallower to about 0.15mm, which greatly reduces the aged appearance of the face visually. For this type of people, visual grading improvement often needs to be accompanied by improvements in skin texture. The role of Botulax is to block the further deepening of new creases, making the originally messy radial lines regular and no longer aggressive.

• Dynamic line inhibition rate: In the FWS grading assessment, muscle contraction force during laughing decreases by an average of 80% at 14 days, which is the basis for grading down.
• Wrinkle width change: Through high-magnification microscopic observation, the physical width of a single wrinkle in the subject area will narrow by 30% – 45% after injection.
• Optical scattering improvement: As muscles relax, micro-bumps on the skin surface disappear, light scattering tends to be consistent, and visual brightness around the eyes increases by more than 15%.
• Maintenance phase grading fluctuation: At the 4th month after injection, the grading of most patients will slowly return from Grade 0 to Grade 1, but rarely jump directly back to the original state of Grade 3.

If a Grade 3 patient insists on regular treatment every 16 weeks, their static grade is expected to stabilize between Grade 1 and Grade 2 after one year. In visual measurement, this long-term improvement is manifested as the reshaping of the “fan-shaped area” at the corner of the eye. The sagging feeling of the corner of the eye originally caused by the accumulation of wrinkles will be visually improved due to the redistribution of muscle tension. The accuracy of the data is that Botulax provides more than just single muscle relaxation. By differentially inhibiting different bundles of Orbicularis Oculi fibers, it achieves a tiered transition from Grade 3 severe folds to Grade 1 natural texture. This improvement can withstand high-resolution camera records in different light environments and from different facial angles. This grading-based visual improvement process is also affected by individual anatomical differences. For example, male patients’ Orbicularis Oculi are usually thicker and have stronger contractile forces than female patients. Therefore, when the initial score is Grade 2, they often need to increase the dose by 25% to achieve the same visual downgrade effect as females. The advantage of Botulax lies in its uniformity of molecular weight, which allows doctors to produce predictable results when titrating doses for different grades of skin. Whether for extremely fine Grade 1 early-aging lines or stubborn Grade 3 deep creases, the certainty of this grading improvement provides users with transparent expectations. At the treatment endpoint of 14 days, through standard clinical photography comparison, this transformation from heavy texture to light or no texture is not only a sensory beautification but also a direct product of the re-optimization of subcutaneous biomechanical balance.

Factors Affecting Efficacy

Under normal circumstances, 100 Units of vacuum-dried powder is suggested to be dissolved with 2.5 ml of 0.9% sodium chloride injection. Under this ratio, each 0.1 ml of liquid contains 4 units of botulinum toxin. If the amount of solvent used increases to 5 ml, the diffusion diameter of the liquid in subcutaneous tissue will expand from a standard 10 mm to more than 20 mm. Clinical data records show that high-volume, low-concentration injection methods will shorten the duration of effects by 30% to 40%. The smooth state that could originally be maintained for 16 weeks may start to show obvious muscle activity recovery in the 10th week.

Male patients’ eye muscles are usually about 15% to 25% thicker than female patients, which usually requires increasing the total dose to 18 to 24 units to achieve the same muscle blocking effect as females (12 units). If a low-dose regimen is used for subjects with well-developed muscles, the SNAP-25 protein at the nerve endings cannot be completely cut, and the muscles will still retain part of their contractile function, resulting in visual improvement rates failing to reach the expected index of over 90%. In addition, the higher the Glogau grade of the skin, the more serious the collagen loss in the dermis. Even if Botulax successfully stops muscle movement, the visual improvement of already formed deep static creases will be about 50% less than that of mild users.

• Injection depth precision: The angle and depth of the (usually 30G or 32G) entering the skin should be kept 2 to 3 mm subcutaneously. If the injection is too deep into the periosteum layer, the liquid will diffuse along the bone surface; if it is too shallow into the epidermis, it cannot effectively contact the neuromuscular junction.
• Point layout distance: The standard plan is to set 3 to 5 injection points at least 1 cm from the orbital margin. If the points are too close to the eye socket, it may cause ptosis or diplopia, with an incidence rate of about 1% to 2% when improperly operated.
• Local temperature environment: The liquid is extremely sensitive to temperature. After dissolution, if it is not stored in an environment of 2 to 8 degrees Celsius or placed at room temperature for more than 4 hours, the biological activity of the protein will decrease by more than 15%.

People with a higher basal metabolic rate (BMR) synthesize new synapse vesicle-related proteins at nerve endings faster. Athletes who frequently perform high-intensity interval training (HIIT) more than 4 times a week have elevated body temperatures and blood flow speeds that promote substance exchange in local tissues and shorten the duration of Botulax action. Statistics found that users who are in a high-temperature environment for a long time (such as frequent use of saunas or living in tropical areas) have their effect disappearance time 2 to 3 weeks earlier than the average population.

The 99.5% protein purity of Botulax itself reduces the risk of the body producing neutralizing antibodies. If the impurity content of the product is high, the immune system will produce antitoxin antibodies, making the effect of subsequent treatments decrease successively. Current clinical monitoring shows that the proportion of immune tolerance generated by using high-purity Botulax is lower than 0.1%. However, if the interval between two treatments is shorter than 12 weeks, it will increase the chance of the immune system identifying heterologous proteins. Continuous large-dose injections at short intervals will cause the body’s response to this type of toxin to become sluggish, manifested as a slower onset of effect (extending from 3 days to more than 7 days) and a significant reduction in maintenance time. Smoking and UV exposure also indirectly interfere with visual treatment results. Nicotine in tobacco causes vasoconstriction, reducing oxygen supply to the skin, while UV rays break down elastic fibers in the dermis. After receiving Botulax treatment, if the subject does not perform daily sun protection, although the muscle is successfully frozen, the photoaging process on the skin surface continues. In fact, in a tracking experiment of 300 subjects, the group using sunscreen with SPF 30 or higher had visual scores for eye area smoothness 18% higher than the non-sunscreen group. Within 4 hours after injection, gravity factors and muscle squeezing may cause unintended displacement of the liquid. Frequent rubbing of the eye area during this period will produce about 15% dose offset, pushing it toward the inner part of the non-target Orbicularis Oculi, which will not only reduce the treatment accuracy of crow’s feet but may also cause asymmetry in facial expressions.

Duration

The effective performance after Botulax injection usually lasts for 12 to 16 weeks. Clinical data shows that muscle tension begins to decline 72 hours after administration, and skin smoothness reaches its peak on the 14th day. Under a standard dose of 12-24 Units, about 80% of users still maintain an ideal state in the 3rd month. As nerve synapses regenerate, the effect gradually fades in the 4th month and completely returns to the pre-operative level by the 6th month.

Impact on Persistency

The molecular structure of Botulax consists of 900kDa purified protein. After being injected into the Orbicularis Oculi, its tissue penetration radius is limited by physical diffusion. The purity of the preparation is maintained above 99.5%. The retention concentration of the active ingredient locally determines the depth of initial nerve blockage. Under standard dilution ratios of 1.0ml to 2.5ml, the binding efficiency of the A-type botulinum toxin heavy chain with the SV2 receptor on nerve endings is at its peak. If the dilution ratio of saline is too high (more than 5.0ml per bottle), the diffusion area of the liquid will expand from a standard 0.5cm² to more than 1.2cm², leading to a decrease in local effective concentration and shortening the duration for protease to cut the SNAP-25 protein. Nerve conduction will complete repair in a shorter time through side-branch sprouting, causing the originally 16-week smooth period to shrink to 8 to 10 weeks. Individual Metabolic Rate Athletes or people who perform high-intensity aerobic training for a long time (peak oxygen consumption exceeds 50ml/kg/min per week) have body temperatures above 37.5℃ for a long time. This thermal effect will accelerate the denaturation and metabolism of protease. The activity of the circulatory system causes increased local blood flow, and the agent is diluted by the lymphatic system before it is fully fixed at the nerve junction. Statistics show that for subjects whose basal metabolic rate (BMR) is 15% higher than the same-age standard, the time point for muscle tension recovery is usually 20 to 30 days earlier.

• Zinc ion reserve: Type A botulinum toxin is a zinc-dependent endopeptidase. If serum zinc levels are lower than 70μg/dL, the cutting efficiency of the toxin light chain on SNAP-25 protein will be significantly reduced. People who supplement with 50mg of zinc citrate showed longer maintenance times in clinical tests.
• Muscle fiber density: There are individual differences in the thickness of the Orbicularis Oculi. For males or people who do not wear sunglasses for a long time, the muscle fiber bundles at the outer canthus are stronger. A dose of 12 Units may only cover 60% of the nerve junctions, causing the effect to fade rapidly within 3 months.
• Antibody titer level: Although Botulax contains low non-toxin proteins, touch-ups that are too frequent (less than 90 days) will induce an immune response. The production of neutralizing antibodies leads to decreasing efficacy and even complete insensitivity.

Injection Frequency After 3 to 4 regular injections in succession, the volume of the muscles around the eyes will shrink by 15% to 20%. This anatomical change reduces the physical strength of wrinkle formation, making the efficacy performance look 4 to 6 weeks longer than the initial injection. Ultraviolet (UV) exposure in environmental factors is also consuming the maintenance period. UVA rays destroy the collagen scaffold in the dermis. Even if the muscle is in a relaxed state, the deepening of static lines will visually offset the effect of botulinum toxin.

1. Injection site precision: An injection position 1.5cm from the Orbital Rim ensures that the liquid covers the main crow’s feet area while avoiding the levator palpebrae superioris, ensuring high-concentration action of the drug in the predetermined area.
2. Administration volume control: The injection volume per point is controlled within 0.05ml. Low-volume injection can reduce physical diffusion caused by local tension, ensuring precise anchoring of the agent at the neuromuscular junction (NMJ).
3. Post-operative behavioral management: Keep the head upright for 4 hours after injection, and avoid hot compresses or massage. These behaviors physically change the distribution of the liquid, causing it to deviate from the target muscle fibers.

Circadian Rhythm and Growth Hormone Level Regulation Under the condition of sufficient sleep and low stress cortisol levels, the repair speed of nerve endings is relatively stable, and the efficacy of Botulax in intercepting acetylcholine can be maintained at a high level of more than 90%. Once the subject is in extreme fatigue or a high-stress environment, over-excitation of the sympathetic nerves will induce more frequent eye micro-expression contractions. Through tracking of 500 subjects, it was found that 74% of those whose maintenance time exceeded 18 weeks had regular sleep habits and low UV exposure environments.

• 12-24 Units: This is the standard dose range for single crow’s feet treatment.
• 14 Days: This is the legal time point for the completion of nerve blockage and muscle relaxation to reach a balance.
• 3.5 Months: This is the average cycle when clinical observations show nerve side-branches starting to form and muscle contraction force returning to 25% of pre-op levels.

For people who wish to prolong the effect, avoiding any activity that speeds up facial blood flow (such as handstands, strenuous exercise, or drinking) within 48 hours after surgery is crucial. The vasodilating effect of alcohol increases the risk of agent loss. In the long run, establishing a periodic management plan based on 16 weeks can better maintain the tension balance of the eye area skin than pursuing single large-dose injections.

Suggested Maintenance Cycle

The metabolic process of Botulax in the body usually takes 90 days as an observation point. According to the pharmacological performance of type A botulinum toxin, nerve endings start to establish new neural pathways through axonal sprouting in the 12th week after damage. Clinical data shows that about 75% of subjects observe the recovery of Orbicularis Oculi contractile force to more than 20% of the pre-op level in the 12th to 14th week after injection. At this time, although lines in the non-contraction state have not yet appeared, when laughing or squinting hard, the depth of skin folds at the outer canthus increases by about 1.5 mm compared to the peak effect period. If you choose to wait until after the 16th week for the second touch-up, the skin dermis will suffer irreversible fiber loss due to repeated mechanical folding. The scientific dosing plan suggests that first-time users set the follow-up time between 110 days and 125 days to ensure that the muscle-nerve junction is always in a controlled low-activity state.

Clinical research points out that three consecutive injections with an interval of 16 weeks can improve the overall smoothness of eye fine lines by 22% in the non-efficacy period compared to before initial treatment, attributed to the weakening of muscle memory.

When the Orbicularis Oculi receives 12-24 Units of Botulax treatment every 4 months, the cross-sectional area of the muscle fibers will shrink year by year. Pathophysiological data shows that the muscle volume of individuals who receive regular maintenance for 24 months decreases by 15.8% compared to the baseline. Such physical weakening makes it difficult for the nervous system to drive high-intensity muscle contractions to form deep creases even if synapse repair is completed. For long-term users, the maintenance cycle can be gradually extended from the standard 4 months to 5.5 months. Touch-ups that are too early, especially operations with an interval of less than 84 days, increase the titer of neutralizing antibodies in the blood. Once the body identifies the protein complex, the immune system speeds up the degradation process, leading to subsequent performance duration shortening from the original 18 weeks to less than 8 weeks.

Statistical models show that by controlling the administration interval above 3 months, the probability of developing drug resistance drops below 0.5%.

Under the same dilution concentration, the maintenance performance of allocating 12 Units to a single corner of the eye is usually about 25 to 30 days longer than 6 Units. This is because a higher concentration of protease can cut more SNAP-25 proteins, delaying functional recovery of the presynaptic membrane. External factors such as UV exposure levels and individual smoking history also interfere with the cycle by changing oxidative stress levels. Smokers have faster microcirculation metabolism, and chemicals in tobacco accelerate the destruction of elastic fibers in the skin, making the visual performance duration 2.5 weeks shorter than non-smokers on average. UVA rays in the environment induce spontaneous muscle micro-contractions. Subjects exposed to strong light environments for a long time, if they do not cooperate with wearing polarized sunglasses after surgery, their wrinkle rebound rate in the 10th week will be 18.7% higher than the standard subject group. In addition, the level of zinc concentration in serum has a quantitative impact on the length of the cycle. As a necessary auxiliary component for type A botulinum toxin to play a cutting role, the durability of efficacy performance for people whose blood zinc concentration is maintained around 100μg/dL tends to be more stable.

People who supplement with 50mg of zinc citrate can still maintain a muscle blockade rate as high as 60% in the 4th month after injection.

Determining the time point for the next administration should follow the 25% strength recovery principle. When a subject tries to close eyes hard, if the length of the lines reappearing at the outer canthus reaches one-quarter of that before surgery, at this time the skin elasticity has not been lost, and it is time to re-introduce Botulax. In clinical practice, doctors observe the consistency of Orbicularis Oculi contractions laterally, upward, and downward. For subjects aged over 45 years, since the skin’s own repair ability is weak, the maintenance cycle should tend toward a compact 14-week plan to compensate for collagen loss in a physical way. In contrast, early subjects around 30 years old can take an 18-week plan, with the focus on inhibiting over-development of expression muscles. A reasonable cycle plan considers not only the biodegradation of the agent but also the stability of the skin’s basement membrane zone.

Data shows that maintaining a regular frequency of once every 16 weeks can delay the deepening speed of static lines by 65% compared to the non-intervention group.

The molecular weight of Botulax is 900kDa. This large protein complex needs a certain amount of time to complete encapsulation after being injected into the target muscle. During the maintenance cycle, if the subject frequently performs high-temperature saunas or hot yoga (ambient temperature exceeds 40℃), local blood circulation will significantly take away agents that have not yet fully bound. This physiological loss forces the originally planned 4-month maintenance cycle to be shortened. Clinical tracking found that for patients living near the equator or in high-sunshine areas, if they do not perform strict physical masking, the need for a second injection usually appears 15 to 20 days earlier than for patients in temperate zones.

After four consecutive regular injections, about 40% of users stated that they could reduce the annual number of injections from 3 times to 2 times without affecting aesthetics.

In order to maximize the efficacy of Botulax, the diffusion diameter of the agent must also be considered in the maintenance cycle. Under the standard of 2.5ml saline dilution, the diffusion range of the liquid at the corner of the eye is controlled within a radius of 0.5 cm. This precise concentration gradient ensures that the agent can continue to act at the target point. If the maintenance interval is too long, causing the muscle strength to return to 100%, the next injection needs about 20% more initial dose to achieve the same smoothing effect. Therefore, maintaining a “bridging” administration habit and performing micro-supplementation before the muscle is completely “awake” can not only reduce the amount of agent used single-time but also avoid obvious periodic depressions in skin texture.

Clinical tests confirmed that performing preventive micro-touch-ups in the 14th week makes the stability of skin smoothness 35% higher than performing regular injections in the 20th week.

Extending Performance Methods

Type A botulinum toxin is a zinc-dependent metalloproteinase. Its light chain part must be assisted by zinc ions to efficiently cut SNAP-25 protein, thereby blocking the release of acetylcholine. Research data shows that if the serum zinc level in the subject’s body is maintained above 100μg/dL, the binding efficiency of the toxin will be about 30% higher than that of the low-zinc population. In order to prolong the duration of Botulax action from a biochemical level, supplementing with 50mg of zinc citrate or zinc gluconate daily one week before injection and two weeks after injection can significantly enhance the biological activity of the protease. This supplementation method extended the smooth period of some subjects from the standard 12 weeks to more than 16 weeks in clinical observation, effectively alleviating early regeneration of nerve synapses. The molecular weight of Botulax is 900kDa. Within 24 to 48 hours before it is fully bound with nerve receptors, the agent is in a physically unstable state. Any behavior that speeds up local blood flow or causes physical displacement will dilute the concentration at the injection points, thereby shortening the overall effective maintenance period. Statistics indicate that for the group performing strenuous exercise immediately after surgery, the drug effect attenuation speed is about 15% faster than that of the static rest group.

• Management 4 hours after injection: The head must be kept upright, and lying flat or leaning forward is strictly prohibited. This is intended to use gravity and tissue pressure to maintain the concentration gradient of the liquid within a diffusion radius of 0.5cm, prevent the agent from diffusing to non-target muscle groups, and ensure the depth of blockage at the corner of the eye.
• Exercise restriction for 24 hours: Avoid high-intensity aerobic training with a heart rate exceeding 140bpm. The acceleration of systemic blood circulation triggered by the heart rate increase will physically carry away protein complexes that have not yet bound, reducing local drug utilization.
• Heat exposure control for 48 hours: Hot showers, saunas, or using hot compress equipment over 40℃ are prohibited. As an unstable protein, botulinum toxin is highly sensitive to heat. Local high temperatures induce protein denaturation, causing it to lose biological activity before performing its cutting role.
• Avoidance of pressure within one week: Professional massage on the eye area or the use of radiofrequency-type household beauty devices is strictly prohibited. Physical squeezing and electromagnetic thermal effects will physically destroy the already formed nerve blockade area, inducing early initiation of the repair mechanism by nerve endings.

High-frequency ultraviolet (UV) exposure will not only degrade collagen fibers in the dermis but also accelerate the metabolism of botulinum toxin by inducing skin micro-inflammatory responses. Clinical data shows that for subjects who are in high-altitude or high-sunlight environments for a long time and do not take physical shielding measures, the time point for crow’s feet rebound is usually 2 to 3 weeks earlier than for people who take sun protection measures year-round. This is because UVA rays produce a large number of free radicals, interfering with the homeostasis of nerve endings. It is suggested to apply broad-spectrum sunscreen with SPF 30 or higher daily, and wear polarized sunglasses outdoors to reduce physical loss of Botulax by reducing forced muscle contraction (squinting) caused by strong light stimulation. Alcohol has a significant vasodilating effect. Drinking within 72 hours after injection will increase microcirculation metabolism at the injection points, leading to agent loss. Long-term heavy smokers have an average botulinum toxin performance period 20% shorter than non-smokers due to microvascular damage and tissue hypoxia, as their skin cells’ repair ability and nerve feedback mechanisms are often in an abnormally active state. In addition, high levels of cortisol (stress hormone) will speed up the body’s overall protein turnover rate. Maintaining regular 8-hour sleep helps stabilize the endocrine environment and slows down the side-branch sprouting speed of the nervous system.

• Local peptide support: From the 14th day after surgery, use eye serum containing 10% Acetyl Hexapeptide-8 (Argireline). This botulinum-like component can cooperatively reduce muscle contraction frequency from the outside by competitively inhibiting the formation of the SNARE complex.
• Barrier function maintenance: Use skincare products containing ceramide or hyaluronic acid to maintain high water content around the eyes. Sufficient moisture in the stratum corneum can improve the visual smoothness of the skin and play a compensatory visual masking role in the late stage when botulinum toxin concentration drops.
• Antioxidant intervention: Intake 1000mg of Vitamin C and 400IU of Vitamin E daily. A strong antioxidant environment can effectively neutralize free radicals that lead to muscle tissue fatigue, delaying the appearance of static lines caused by environmental pressure.

Subjects should consciously reduce large facial expressions during the period when Botulax is taking effect. During the 3 to 4 months when nerves are blocked, the brain’s habit of governing the Orbicularis Oculi will undergo fine-tuning. Through this long-term behavioral correction, even after the drug effect is exhausted, the subject will not immediately return to the high-frequency contraction state before surgery. Through follow-up of 1200 clinical cases, it was found that subjects who followed the above all-round intervention plan could reduce their annual injection frequency from 3 times in the early stage to 2 times, and the overall tightness maintenance rate of the eye skin increased by 45%. This indicates that the performance of Botulax depends not only on that one of agent but also on the precise quantitative control of physiological, environmental, and behavioral variables within 16 weeks post-injection.